FDA Unveils New Framework for Approving COVID Shots
- May 23, 2025
The Food and Drug Administration (FDA) plans to require additional clinical trials before approving COVID-19 booster shots for healthy individuals between the ages of six months and 64 under a new policy announced this week.
ARTICLE TAGS
You must be logged in to access this content.